The concept of diversification is central in finance and has become even more so since the
2008 financial crisis. In this article, the authors introduce a new measure for diversification. …

Background Targeting the immune checkpoint pathway has demonstrated antitumor cytotoxicity
in treatment-refractory head and neck squamous cell carcinoma (HNSC). To understand …

… Vermorken is the corresponding author and can be contacted at: m.vermorken@ucl.ac.uk …
Vermorken is a Master student in Business Engineering at Solvay Brussels School in …

Non-small cell lung cancer (NSCLC) accounts for 80–85% of all lung cancer which is the
leading cause of cancer death worldwide. Eighty percent of NSCLC patients exhibit high levels …

Purpose To comprehensively assess the reporting quality of randomized, controlled trials (RCTs)
in nasopharyngeal carcinoma (NPC), and to identify significant predictors of quality. …

… Vermorken. Merck sponsored the trial and performed the … Vermorken vouches for the
completeness and accuracy of the data and analyses. The article was written by Dr. Vermorken, …

Background Phase 2 studies suggest that the standard regimen of cisplatin and fluorouracil (PF)
plus docetaxel (TPF) improves outcomes in squamous-cell carcinoma of the head and …

Background Originating from the nasopharyngeal epithelium, nasopharyngeal carcinoma (NPC)
is an Epstein-Barr virus (EBV)-related cancer that features an extremely uneven …

Purpose The objective of this study was to compare the efficacy and safety of trabectedin
plus pegylated liposomal doxorubicin (PLD) with that of PLD alone in women with recurrent …

The isolated lenticular plasma membrane-cytoskeleton complex, when analysed by sodium
dodecylsulphate-polyacrylamide gel electrophoresis, shows reproducibly a significant …